BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kovvuru S, Cardenas YC, Huttner A, Nowak RJ, Roy B. Clinical characteristics of fibroblast growth factor receptor 3 antibody-related polyneuropathy: a retrospective study. Eur J Neurol 2020;27:1310-8. [PMID: 32068339 DOI: 10.1111/ene.14180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Antoine JC. Sensory neuronopathies, diagnostic criteria and causes. Curr Opin Neurol 2022. [PMID: 35950727 DOI: 10.1097/WCO.0000000000001105] [Reference Citation Analysis]
2 Tholance Y, Antoine JC, Mohr L, Jung M, Reynaud-Federspiel E, Ferraud K, Camdessanché JP, Moritz CP. Anti-FGFR3 antibody epitopes are functional sites and correlate with the neuropathy pattern. J Neuroimmunol 2021;361:577757. [PMID: 34768040 DOI: 10.1016/j.jneuroim.2021.577757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fujii T, Lee EJ, Miyachi Y, Yamasaki R, Lim YM, Iinuma K, Sakoda A, Kim KK, Kira JI. Antiplexin D1 Antibodies Relate to Small Fiber Neuropathy and Induce Neuropathic Pain in Animals. Neurol Neuroimmunol Neuroinflamm 2021;8:e1028. [PMID: 34099459 DOI: 10.1212/NXI.0000000000001028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Trevino JA, Novak P. TS‐HDS and FGFR3 antibodies in small fiber neuropathy and Dysautonomia. Muscle & Nerve 2021;64:70-6. [DOI: 10.1002/mus.27245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Nagarajan E, Kang SA, Holmes C, Govindarajan R. Clinical features with anti fibroblast growth factor receptor 3 (FGFR3) antibody-related polyneuropathy: a retrospective study. BMC Neurol 2021;21:74. [PMID: 33588772 DOI: 10.1186/s12883-021-02090-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Fargeot G, Echaniz-laguna A. Sensory neuronopathies: new genes, new antibodies and new concepts. J Neurol Neurosurg Psychiatry 2021;92:398-406. [DOI: 10.1136/jnnp-2020-325536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Tholance Y, Moritz CP, Camdessanché JP, Antoine JC. What is the pattern of the neuropathy associated with anti‐FGFR3 antibodies? Eur J Neurol 2020;27. [DOI: 10.1111/ene.14376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kira J. 5) The Cutting Edge of Pathomechanism and Therapy for Intractable Neuroimmunological Diseases. J Jpn Soc Intern Med 2020;109:1764-1774. [DOI: 10.2169/naika.109.1764] [Reference Citation Analysis]
9 Roy B, Kovvuru S, Castillo YC, Huttner A, Nowak RJ. Reply to: What is the pattern of the neuropathy associated with anti-FGFR3 antibodies? Eur J Neurol 2020;27:e59. [PMID: 32503081 DOI: 10.1111/ene.14381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]